Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues - PubMed (original) (raw)

. 1990 Jan 4;343(6253):90-2.

doi: 10.1038/343090a0.

Affiliations

Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues

T D Meek et al. Nature. 1990.

Abstract

The gag and pol genes of the human immunodeficiency virus type 1 (HIV-1) (ref. 1) are translated as two polyproteins, Pr55gag and Pr160gag-pol (refs 2-6), which are subsequently cleaved by the action of a virus-encoded protease into the four structural gag proteins of the virion core (p17, p24, p7 and p6) and the pol-encoded enzymes essential for retrovirus replication (protease, reverse transcriptase, ribonuclease H, and endonuclease). Mutational inactivation of the proteases of HIV-1 and other retroviruses results in immature, non-infectious virions, indicating that exogenous inhibition of the protease may represent an attractive approach to anti-AIDS therapy. Here we demonstrate that synthetic peptide analogues, which are potent inhibitors of purified HIV-1 protease, inhibit the processing of the viral polyproteins in cultures of HIV-1-infected T lymphocytes and attenuate viral infectivity.

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

Substances

LinkOut - more resources